Wells Fargo Maintains Overweight on Sempra, Raises Price Target to $115

Wells Fargo analyst Shahriar Pourreza has maintained an Overweight rating on Sempra (NYSE: SRE) and increased the price target from $113 to $115. This adjustment reflects a positive outlook on the company's performance.